Contract 75N93024C00054
Translational Genomics Research Institute · Department Of Health And Human Services · September 24, 2024
Translational Genomics Research Institute was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 24, 2024 for $2.55 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Phoenix, AZ. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on September 23, 2025. If all options are exercised, the contract could reach $6.78 million.
Contract details
- PIID
- 75N93024C00054
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Phoenix, AZ
- First action
- September 24, 2024
- Latest action
- September 23, 2025
Description
EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN PO
Modification timeline
-
September 23, 2025Mod P00001 · Change Order$2.55M
-
September 24, 2024Base awardMYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS$1.50M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93024C00054?
Contract 75N93024C00054 is a federal contract awarded to Translational Genomics Research Institute by Department Of Health And Human Services on September 24, 2024 for $2.55 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N93024C00054?
Translational Genomics Research Institute won contract 75N93024C00054 from Department Of Health And Human Services.
How much is contract 75N93024C00054 worth?
Contract 75N93024C00054 has obligated $2.55 million to date, with a total potential value of $6.78 million if all options are exercised.